Abstract blue circuit board with glowing data bars

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

1 minute read

Published: November 16th, 2026

When clinical development programs face quality concerns, resource shortages, or submission risks, sponsors need a partner they can trust to deliver. 

In this case study, discover how Phastar helped a top ten pharmaceutical company recover 12 studies from an underperforming supplier, support a critical regulatory submission, and ultimately become one of the sponsor’s preferred strategic partners. 

By combining statistical expertise, proactive consultancy, and reliable delivery, Phastar helped protect submission timelines, restore confidence in study reporting, and support long-term development success. 

Download the full case study to see how Phastar helps sponsors overcome operational challenges and deliver high-quality, submission-ready clinical trial reporting.

Related articles

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

November 16th, 2026 1 minute read

When a bioequivalence study fails to meet regulatory criteria, understanding why is critical for successful developme...

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

November 16th, 2026 1 minute read

Data Monitoring Committees play a vital role in safeguarding patient safety and supporting informed decision-making t...

Supporting a Global HIV Development Program Through Independent IDMC Oversight and Statistical Leadership

Supporting a Global HIV Development Program Through Independent IDMC Oversight and Statistical Leadership

November 16th, 2026 1 minute read

As clinical development programmes grow in scale and complexity, sponsors need confidence that safety and efficacy re...